Latest / Understanding the Brain / Why Does the Brain React When Its Chemistry Changes? The Neuroscience of Withdrawal
Transcript
- 0:01Speaker 1: Today we look at brain zaps. Why stopping? Certain types
- 0:05Speaker 1: of medications like Cymbalta or Effexor can feel like electric
- 0:09Speaker 1: shocks in your head. If a person is taking Cymbalta
- 0:12Speaker 1: and forgets their medication one morning, by the following day
- 0:15Speaker 1: something unusual begins to happen. Every time they turn their
- 0:18Speaker 1: head or move their eyes, they experience a brief sensation
- 0:20Speaker 1: resembling an electrical shock inside their skull. Some describe it
- 0:25Speaker 1: as a sudden jolt. Others compare it to a buzzing sensation.
- 0:28Speaker 1: or a momentary electrical pulse. These sensations have become widely
- 0:32Speaker 1: known as brain zaps. But what is happening? To understand
- 0:35Speaker 1: the phenomenon, we need to examine how antidepressants influence communication
- 0:39Speaker 1: between nerve cells. Cymbalta, known generically as duloxetine, belongs to
- 0:44Speaker 1: a class of medications called SNRIs, serotonin and norepinephrine reuptake inhibitors.
- 0:50Speaker 1: Neurons communicate by releasing chemical messengers called neurotransmitters. The two
- 0:55Speaker 1: important ones here are serotonin and norepinephrine, which are mood regulations. Normally,
- 0:59Speaker 1: after these chemicals are released into the space between the neurons,
- 1:02Speaker 1: you probably remember the synaptic cleft, specialized transport proteins help
- 1:06Speaker 1: remove them through a process called reuptake. They either take
- 1:09Speaker 1: them back in or they diffuse them later. However, Cymbalta
- 1:13Speaker 1: inhibits these transporters, these taxicabs per se, increasing the availability
- 1:18Speaker 1: of serotonin and norepinephrine. However, the brain is not a
- 1:22Speaker 1: passive recipient of medication. Over weeks and months, neural systems
- 1:26Speaker 1: adapt to changes in neurotransmitter signaling. Receptor sensitivity, intracellular signaling pathways,
- 1:32Speaker 1: and other regulatory processes may adjust as the nervous system
- 1:34Speaker 1: attempts to maintain stability. So what happens when someone abruptly
- 1:38Speaker 1: stops taking the medication? Cymbalta has an elimination half-life of
- 1:42Speaker 1: about 12 hours. This means that, on average, the amount
- 1:46Speaker 1: of medication in the bloodstream declines by roughly half every
- 1:49Speaker 1: 12 hours after absorption and distribution are accounted for. After
- 1:53Speaker 1: 24 hours, approximately one-quarter of the original amount may remain.
- 1:58Speaker 1: After 48, just about 6%. These are simplified estimates, and
- 2:03Speaker 1: individual metabolism varies. But the important part is that medication
- 2:06Speaker 1: exposure can decline much faster than the nervous system reverses
- 2:09Speaker 1: its adaptations. The mismatch is believed to contribute to what
- 2:13Speaker 1: they call antidepressant discontinuation syndrome. On a side note, Prozac
- 2:18Speaker 1: has one of the longer half-lives of most of the
- 2:20Speaker 1: antidepressants and also has active metabolites, which keeps it still
- 2:24Speaker 1: active for at least another two weeks or so. Let's
- 2:28Speaker 1: go back. Symptoms of discontinuation syndrome may include dizziness, nausea,
- 2:33Speaker 1: sleep disturbances, flu-like sensations, and the brain zaps. But why
- 2:37Speaker 1: the brain zaps? Well, scientists still don't know the precise
- 2:41Speaker 1: mechanism of this. A hypothesis involves temporary changes in sensory
- 2:46Speaker 1: processing as sebidrenergic and noradrenergic signaling readjusts. Another possibility involves
- 2:51Speaker 1: the vestibular system, which helps coordinate balance and head movement.
- 2:55Speaker 1: This is interesting because some people report that moving their
- 2:58Speaker 1: eyes from side to side triggers the sensation. Researchers have
- 3:01Speaker 1: suggested that changes in communication among sensory, vestibular, and brain
- 3:05Speaker 1: step networks might contribute. Brain zaps are not known to
- 3:09Speaker 1: represent actual electrical shocks or seizures. Their electrical quality describes
- 3:12Speaker 1: the person's subjective experience rather than electrical discharge. That's important.
- 3:17Speaker 1: Not all of this antidepressants also produce the same discontinuations
- 3:20Speaker 1: I mentioned. Prozac has a long-lasting effect. It has a
- 3:24Speaker 1: long half-life and a long-lasting active metabolite called neurofluoxetine. By contrast,
- 3:32Speaker 1: duloxetine or Cymbalta, Effexor, and Paxil generally have higher discontinuation risks.
- 3:38Speaker 1: For most people, discontinuation symptoms are temporary, although some experience
- 3:42Speaker 1: prolonged or particularly distressing symptoms. The lesson here is that
- 3:46Speaker 1: brain zaps reveal something fundamental about neuroscience. The brain is
- 3:49Speaker 1: constantly adapting to its chemical environment. When that environment changes suddenly,
- 3:54Speaker 1: neural systems may require to recreate equilibrium.